1-4 of 4
Gustavo Reyes, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nilotinib (AMN107) Can Induce Complete Cytogenetic Responses (CCyR) and Molecular Responses in Patients (Pts) with Advanced Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib Mesylate (IM). Report of the Compassionate Use Program of Nilotinib in Mexico

Manuel Ayala, MD, Rafael Hurtado Monroy, MD, Luis Meillon, MD, Nancy Delgado, MD, Elena Garcia, MD, Jorge Vela-Ojeda, MD, Pablo Vargas, MD, Norma Tapia, MD, Martha Alvarado, MD, Jose de Diego, MD, Patricio Azaola, MD, Roberto Hernandez, MD, Gustavo Reyes, MD, Martín de Jesús Gonzalez, MD, Alvaro Aguayo, Juan Julio Kassack, MD, Sergio Cleto, MD, Olga Cantu, MD, Kevin Nacho, MD, Angel Herrera, Ingrid Mucius
Journal: Blood
Blood (2008) 112 (11): 4275.
https://doi.org/10.1182/blood.V112.11.4275.4275
Published: 2008
Journal Articles

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Francisco Tripp, MD, Enrique Báez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Oscar Garcés, MD, Gustavo Reyes, MD, Benjamín Batista, MD, Alva Zaragoza, MD, Jorge Vela-Ojeda, MD, Luis Villela, MD
Journal: Blood
Blood (2007) 110 (11): 4489.
https://doi.org/10.1182/blood.V110.11.4489.4489
Published: 2007
Journal Articles

Compassionate Use of Nilotinib (AMN107) in Mexican Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib.

Manuel Ayala, MD, Rafael Hurtado, MD, Kevin Nacho, MD, Norma Tapia, MD, Martha Alvarado, MD, Alvaro Aguayo, MD, Sergio Cleto, MD, Yolanda Lugo, MD, Gustavo Reyes, MD, Pablo Vargas, MD, Angel Herrera, Luis Antonio Meillon, MD
Journal: Blood
Blood (2007) 110 (11): 4578.
https://doi.org/10.1182/blood.V110.11.4578.4578
Published: 2007
Journal Articles

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Silvia Rivas-Vera, MD, Enrique Baez, MD, Pedro Sobrevilla-Calvo, MD, Severiano Baltazar, MD, Francisco Tripp, MD, Jorge Vela, MD, Oscar Garces, MD, Luis Aguilar, MD, Gregorio Ignacio, MD, Jorge Duque, MD, Petty Rodriguez, MD, Gustavo Reyes, MD
Journal: Blood
Blood (2005) 106 (11): 2431.
https://doi.org/10.1182/blood.V106.11.2431.2431
Published: 2005